NV

Npj Vaccines

npj Vaccines is part of the npj Series and is published in partnership with the University of Texas Medical Branch. It publishes vaccine research and reports a 2-year impact factor of 6.6 (2024), 3,901,115 article downloads in 2025, and 13 days from submission to first editorial decision (2025).

Looking to publish in Npj Vaccines? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology, Medicine, Research & Experimental
Impact Factor 6.5
Quartile Q1
Open Access Type Open
eISSN 2059-0105
Invitation Only No
Cost Range Article processing charge (APC) applies; current APCs and waiver information are available via the APC section.

Submission Instructions

Npj Vaccines accepts the following article types. Click on an article type to view submission instructions.

Article

Cover Letter Cover letter must accompany the submission.
Abstract Abstract is required. Abstract must be no more than 150 words. Abstract must be unstructured with no subheadings.
Manuscript Manuscript must include an Introduction with no subheadings, Results with subheadings, Discussion with no subheadings and no limitations or conclusions section, and Methods with subheadings, with all Methods content included in the main manuscript file. Manuscript must include a Data availability section, an Author contributions statement naming all authors by initials, a Competing Interests statement, and funding information in the Acknowledgments rather than in a separate Funding statement.
References References are limited to 60, though this limit is not strictly enforced.
Figures & Tables Figure legends must be no more than 350 words per figure, and multi-panel figures must appear on a single page with panels labeled a), b), c), and so on.
Reformat to Npj Vaccines using Livewrite Premium

Review

Cover Letter A cover letter must accompany the submission.
Abstract Abstract must be no more than 70 words. Abstract must be unstructured with no subheadings.
Manuscript Main text is typically 3,000–4,000 words in length. Main text may include subheadings. The manuscript must include an Author contributions statement identifying each author by initials and a Competing Interests statement declaring financial and non-financial competing interests or stating that none exist.
References References are limited to 60, though this limit is not strictly enforced.
Figures & Tables Figure legends must be no more than 350 words per figure, and multi-panel figures must appear on a single page with panels labeled a), b), c), and so on.
Reformat to Npj Vaccines using Livewrite Premium

Brief Communication

Cover Letter A cover letter must accompany the submission.
Abstract An abstract is required. Abstract must be no more than 70 words. Abstract must be unstructured with no subheadings.
Manuscript Main text should be 1,000-1,500 words, excluding the abstract, methods, references, and figure legends. Main text must have no subheadings, while the Methods section must use subheadings. The manuscript must include an Author contributions statement naming all authors by initials, a Competing Interests statement for each author, and a Code availability section where applicable.
References References should be around 20.
Figures & Tables Methods descriptions must be included in the main manuscript file rather than in the Supplementary Information. Figure legends must be limited to 350 words per figure, and multi-panel figures must appear on a single page with panels labeled a), b), c), and so on.
Reformat to Npj Vaccines using Livewrite Premium

Case Report

Cover Letter Cover letter must accompany the submission.
Abstract Abstract must be no longer than 150 words. Abstract must be unstructured with no subheadings.
Manuscript Manuscript must include Methods, Results, and Discussion sections, with subheadings required in Methods and Results and prohibited in Discussion. Manuscript must include a mandatory Author contributions statement identifying each author by initials, a mandatory Competing Interests statement for each author, and a mandatory Data availability section, with a Code availability section included where applicable.
References References should be around 50 as a guide.
Figures & Tables Multi-panel figures must be presented on a single page with panels labeled a), b), c), and figure legends must not exceed 350 words per figure.
Reformat to Npj Vaccines using Livewrite Premium

Recent Publications

Quillaja saponaria fraction QS-18 as an adjuvant for liposomal seasonal influenza vaccines

Qinzhe Li, Zachary Sia, Yuan Luo, Wei-Chiao Huang, Hilliard L. Kutscher, Haojun Zhu, Joaquin Ortega, Bruce A. Davidson, Jonathan F. Lovell

10.1038/s41541-026-01457-1
View Publication

Preclinical efficacy of dendritic cells loaded with newly identified HPV11 E6-derived CD8+ T cell epitopes

Laurie Baert, Chao Gu, Agnes Yang, HyeMee Joo, Richard Kennedy, Kieth Knutson, David G. Lott, SangKon Oh

10.1038/s41541-026-01466-0
View Publication

HER-2 therapeutic vaccine is not hampered by concurrent HER-2 monoclonal antibody

Maria Sofia Semprini, Chiara Cappello, Laura Scalambra, Olga Maria Pittino, Stefania Angelicola, Patrizia Nanni, Pier-Luigi Lollini, Francesca Ruzzi

10.1038/s41541-026-01462-4
View Publication

Influenza mRNA vaccine with engineered panhandle-forming UTRs provides potent, dose-sparing protection against seasonal influenza viruses

Yifan Xu, Xuehua Wan, Mingzhuo Chen, Benchi Li, Qian Weng, Qin Wang, Zhiliang Hu, Yongxiang Yi, Junwei Li

10.1038/s41541-026-01463-3
View Publication

Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21

Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, Lais Da Silva Pereira, Marlon Dillon, Baoshan Zhang, Mariah Lofgren, Katelyn T. Nguyen, I-Ting Teng, Brian Bonilla, Sarah Kerscher, Wing-Pui Kong, Amy R. Henry, Tyler Stephens, Yaroslav Tsybovsky, Stephanie R. Weldon, Daniel C. Douek, Theodore C. Pierson, Facundo D. Batista, Azza H. Idris, Robert A. Seder, Peter D. Kwong, Tongqing Zhou

10.1038/s41541-026-01455-3
View Publication

Frequently asked questions

How long does it take to publish?

13 days from submission to first editorial decision (2025).

Reformat to Npj Vaccines using Livewrite Premium

Is a cover letter required?

A cover letter is required for all submissions.

Reformat to Npj Vaccines using Livewrite Premium

What are the publication costs?

Research Topics

SARS-CoV-2 and COVID-19 Research Immunotherapy and Immune Responses Influenza Virus Research Studies Mosquito-borne diseases and control Viral gastroenteritis research and epidemiology Respiratory viral infections research Viral Infections and Vectors vaccines and immunoinformatics approaches Animal Virus Infections Studies Viral Infections and Outbreaks Research Malaria Research and Control COVID-19 Clinical Research Studies Vaccine Coverage and Hesitancy HIV Research and Treatment Virology and Viral Diseases Immune Response and Inflammation Viral Infections and Immunology Research Immune responses and vaccinations RNA Interference and Gene Delivery Herpesvirus Infections and Treatments Pneumonia and Respiratory Infections Bacterial Infections and Vaccines Monoclonal and Polyclonal Antibodies Research Immune Cell Function and Interaction T-cell and B-cell Immunology

Related Journals

JO
Journal Of Virus Eradication Elsevier BV
EM
Emerging Microbes & Infections Taylor & Francis
CG
Cancer Gene Therapy Springer Nature
Tu
Tuberculosis Elsevier BV
JO
Jaids-journal Of Acquired Immune Deficiency Syndromes LIPPINCOTT WILLIAMS & WILKINS
JO
Journal Of Allergy And Clinical Immunology Elsevier BV